Bibliography
- GRABOWSKI HG, WANG YR: The quantity and quality of worldwide new drug introductions, 1982 – 2003. Health Affairs (2006) 25(2):452-460.
- RAO SM: Neuropsychology of multiple sclerosis: a critical review. J. Clin. Exp. Neuropsychol. (1986) 8(5):503-542.
- FOX EJ: Immunopathology of multiple sclerosis. Neurology (2004) 63:S3-S7.
- KIESEIER BC, HARTUNG HP: Current disease-modifying therapies in multiple sclerosis. Semin. Neurol. (2003) 23:133-146.
- OLANOW CW, TATTON WG: Etiology and pathogenesis of Parkinson's disease. Ann. Rev. Neurosci. (1999) 22:123-144.
- COYLE JT: Drug treatment of anxiety disorders in children. N. Engl. J. Med. (2001) 344(17):1326-1327.
- CANNISTRARO PA, RAUCH SL: Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. Psychopharmacol. Bull. (2003) 37:8-25.
- LANG PJ, DAVIS M, ÖHMAN A: Fear and anxiety: animal models and human cognitive psychophysiology. J. Affect. Disord. (2000) 61:137–159.
- BISHOP SJ: Neurocognitive mechanisms of anxiety: an integrative account. Trends Cog. Sci. (2007) 7:307-316.
- SPECIALE L, CALABRESE E, SARESELLA M et al.: Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol. Aging (2007) 28:1163-1169.
- FLETCHER CF, LUTZ CM, O'SULLIVAN TN et al.: Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell (1996) 87:607-617.
- COLLINS SD, CHESSELL IP: Emerging therapies for neuropathic pain. Expert Opin. Emerging Drugs (2005) 10(1):95-108.
- GOADSBY PJ, LITPN RB, FERRARI MD: Migraine – current understanding and treatment. N. Engl. J. Med. (2002) 346:257-270.
Websites
- http://www.who.int WHO: mental health.
- http://www.pharmaprojects.com The Pharmaprojects database. Copyright © Informa UK Ltd (2007).